A short list of new highs shows a wide divergence in the path stocks took to get there.
Application Software placed two names on today’s list. As of Monday, September 21, there are 9 Small Cap US and Canada-listed stocks in the Trefis coverage universe trading at their 52-week highs. The largest company on the list is Silicon Laboratories (SLAB), with a market value of about $7.3 billion, which has gained 1.3% over the last month.
That quiet arrival contrasts with the strongest one-month run on the list, a gain of 54.4% for Schrodinger (SDGR). How can two stocks reach their highest price of the past year on such different trajectories?
Every Name On The List
Here are all 9 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| SLAB | $7.33 Bil | 0.2% | 0.7% | 1.3% | 56.3% |
| ACA | $7.18 Bil | 0.3% | 0.7% | 0.6% | 51.1% |
| RNG | $6.5 Bil | 7.6% | 6.9% | 17.9% | 143.9% |
| AMRX | $6.44 Bil | 7.7% | 17.1% | 12.6% | 105.5% |
| NEOG | $2.96 Bil | 4.7% | 13.9% | 15.0% | 140.0% |
| CDNA | $2.8 Bil | 0.9% | 3.7% | 15.6% | 267.8% |
| FIVN | $2.79 Bil | 14.0% | 16.6% | 14.6% | 39.2% |
| SDGR | $2.26 Bil | 4.2% | 45.7% | 54.4% | 53.9% |
| TH | $2.13 Bil | 0.4% | 14.7% | 20.7% | 147.7% |
This screen covers US and Canada-listed stocks in the Trefis coverage universe. Small Cap here means a market value between $2 billion and $10 billion, the upper figure excluded.
Does a higher price always come with stronger growth?
The list offers different answers. RingCentral (RNG) reached its new high after a 17.9% gain over the last month. The company trades at 58.9 times trailing earnings, and its revenue grew 5.2% over the last twelve months, and its operating margin was 6.7%.
Compare that to Arcosa (ACA), which made the list on a 0.6% one-month gain. Arcosa trades at 14.6 times trailing earnings, while its revenue grew 9.7% over the last twelve months and its operating margin was 11.8%.
So is a 52-week high a signal to buy or a warning?
A stock trading at its highest price of the past year is a sign of strength, and that strength can persist. But a price is just a price. It is not a verdict on the underlying business or its future.
The disciplined next step is not to chase the number on the screen. It is to ask whether the company’s fundamentals, its growth and its margins, justify the new valuation.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks.
Strength Is A Clue. It Is Not A Plan
A stock at its 52-week high has momentum on its side, and momentum is a real force. It is also the most crowded signal in the market, and what separates a run that lasts from one that tops is usually the business underneath.
Checking that business, across thousands of names, is how the Trefis High Quality (HQ) Portfolio is assembled: roughly 30 companies that pass the quality screens, rebalanced on rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Let the highs point; let the discipline decide.
Leave a Reply